News
-
-
-
PRESS RELEASE
New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details -
-
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Disclosure of total voting rights and capital by EUROFINS SCIENTIFIC SE including changes from cancellation of beneficiary units and treasury share purchase -
-
-
-